Bioventus (BVS) EBITDA Margin Growth (3y) (2023 - 2026)
Bioventus (BVS) EBITDA Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 176.24 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 129.03 Bn | 126.15 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 108.43 Bn | 99.21 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 68.74 Bn | 67.28 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn | -283.00 |
| 6 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 1,505.00 |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.78 Bn | 1.98 Bn | -184.00 |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | -763.00 |
| 10 | Bioventus | 824.72 Mn | 788.87 Mn | 90.77 Mn | 8,369.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 8,369.00 |
| Dec 31, 2025 | 2,477.00 |
| Sep 27, 2025 | 10,670.00 |
| Jun 28, 2025 | 1,480.00 |
| Mar 29, 2025 | 2,222.00 |
| Dec 31, 2024 | 743.00 |
| Sep 28, 2024 | 359.00 |
| Jun 29, 2024 | -1,559.00 |
| Mar 30, 2024 | -2,309.00 |
| Dec 31, 2023 | -513.00 |
| Sep 30, 2023 | -607.00 |
| Jul 1, 2023 | 1,284.00 |
| Apr 1, 2023 | -9,384.00 |